Sage confirms Biogen’s bid to acquire remaining stake
Sage Therapeutics (NASDAQ:SAGE) has confirmed that the Alzheimer’s drug developer Biogen (NASDAQ:BIIB) has offered to buy all ...
Weekly Roundup Jan. 5-11, 2025
Discover a proven 5-step plan to safeguard your inheritance and achieve your financial goals. Financial adviser Jeffrey ...